[en] Although, in many respects and from a metabolic point of view, obesity and AN are clearly two opposite pathological conditions, the available data concerning insulin sensitivity in these two syndromes are not so obviously opposite. Indeed, whereas everybody is convinced that obesity is characterized by an increased insulin resistance, the papers reporting insulin sensitivity parameters in AN contain some apparently contradictory results. The observations of simultaneously low fasting blood glucose and plasma-insulin levels in anorectic patients could suggest increased insulin sensitivity in AN. However, if this is the case, it would be present despite other metabolic and hormonal changes (increased plasma concentrations of free fatty acids, cortisol, and growth hormone) which are known factors of insulin resistance. During an oral glucose-tolerance test, an impaired glucose-tolerance occurring despite sustained insulin response to glucose is usually found in anorectic patients before treatment; these abnormalities are, at least partially, reversed after successful refeeding. From these results, such conclusive, if indirect, evidence exists for relative insulin insensitivity in untreated AN. Similar results were initially reported with the intravenous glucose-tolerance test. Typically, the coefficient of glucose assimilation K was reduced in anorectic patients before treatment and increased after realimentation. This seemed to occur despite a relative increase in insulin response to glucose, which again may be related to insulin resistance in these undernourished subjects. However, more recent data demonstrated that the early insulin response is significantly lower in anorectic patients than in controls and that more than half of these patients have normal glucose-tolerance despite decreased peripheral plasma insulin levels. These latter observations, on the contrary, suggest an increased insulin sensitivity, at least in some patients with AN. Only the recently developed minimal model method allows us to discriminate between changes in insulin secretion and action after intravenous glucose injection and thus to infer accurately the sensitivity of the tissues to insulin. Unfortunately, this technique has not been applied to anorectic patients, until now, to solve the controversy. The simplest way to assess the action in vivo of insulin is to perform an intravenous insulin-tolerance test. However, the initial findings with this test, which showed exaggerated fall in plasma-glucose values and delayed return to basal levels after intravenous injection of insulin in AN, do not necessarily mean increased insulin sensitivity in these self-starved patients.(ABSTRACT TRUNCATED AT 400 WORDS)
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Castillo, M.
Lefebvre, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Language :
English
Title :
Insulin sensitivity in anorexia nervosa: a mirror image of obesity?
Drossman DA, Ontjes DA, Heizer WD (1979) Anorexia nervosa. Gastroenterology 77:1115-1131.
Schwabe AD, Lippe BM, Chang RJ, Pops MA, Yager J (1981) Anorexia nervosa. UCLA Conference. Ann Intern Med 94:371-381.
Herzog DB, Copeland PM (1985) Eating disorders. N Engl J Med 313:295-303.
Kolterman OG, Insel J, Saekow M, Olefsky M (1980) Mechanism of insulin resistance in human obesity. Evidence for receptor and postreceptor defects. J Clin Invest 65:1272-1284.
Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocrinol Rev 6:45-86.
Landon J, Greenwood FC, Stamp TCB, Wynn V (1966) The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa. J Clin Invest 45:437-449.
Crisp AH, Ellis J, Lowy C (1967) Insulin response to a rapid intravenous injection of dextrose in patients with anorexia nervosa and obesity. Postgrad Med J 43:97-102.
Mecklenburg RS, Loriaux DL, Thompson RH, Andersen AE, Lipsett MB (1974) Hypothalamic dysfunction in patients with anorexia nervosa. Medicine 53:147-159.
Sizonenko PC, Rabinovitch A, Schneider P, Paunier L, Wollheim CB, Zahnd G (1975) Plasma growth hormone, insulin, and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism and anorexia nervosa. Pediatr Res 9:733-738.
Blickle JF, Reville P, Stephan F, Meyer P, Demangeat C, Sapin R (1984) The role of insulin, glucagon and growth hormone in the regulation of plasma glucose and free fatty acid levels in anorexia nervosa. Horm Metab Res 16:336-340.
Zalin AM, Lant AF (1984) Anorexia nervosa presenting as reversible hypoglycaemic coma. J Roy Soc Med 77:193-195.
Ratcliffe PJ, Bevan JS (1985) Severe hypoglycaemia and sudden death in anorexia nervosa. Psych Med 15:679-681.
Marks V (1976) Hypoglycaemia. 2. Other causes. Clin Endocrinol Metab 5:769-782.
Stephan F, Schlienger JL, Blickle JF, de Laharpe F (1982) Adaptations endocriniennes à la dénutrition chronique chez l'anorectique mentale. Nouv Presse Med 11:1055-1058.
Zuniga‐Guajardo S, Garfinkel PE, Zinman B (1986) Changes in insulin sensitivity and clearance in anorexia nervosa. Metabolism 35:1096-1100.
Russel GFM (1965) Metabolic aspects of anorexia nervosa. Proc R Soc Med 58:811-814.
Warren MP, Vande Wiele RL (1973) Clinical and metabolic features of anorexia nervosa. Am J Obstet Gynecol 117:435-449.
Frankel RJ, Jenkins JS (1975) Hypothalamic‐pituitary function in anorexia nervosa. Acta Endocrinol 78:209-221.
Kanis JA, Brown P, Fitzpatrick K, Hibbert DJ, Horn DB, Nairn IM, Shirling D, Strong JA, Walton HJ (1974) Anorexia nervosa: A clinical, psychiatric and laboratory study. Q J Med 43:321-338.
Fliederbaum J (1979) Metabolic changes in hunger disease. Hunger Disease: Studies by the Jewish Physicians in the Warsaw Ghetto , Winick M, John Wiley & Sons, New York; 69-114.
Crisp AH (1965) Some aspects of the evolution, presentation and follow‐up of anorexia nervosa. Proc R Soc Med 58:814-820.
Stephan F, Reville P, Thierry R, Schlienger JL, Doerflinger MA, Kammerer C (1973) Glycémie, insulinémie et somatotrophine plasmatique au cours d'épreuves de surcharge chez des dénutris par anorexie mentale. Ann Endocrinol 34:1-15.
Hirvonen E, Seppälä M, Karonen SL, Adlercreutz H (1977) Luteinizing hormone responses to luteinizing hormone releasing hormone, and growth hormone and cortisol responses to insulin induced hypoglycaemia in functional secondary amenorrhoea. Acta Endocrinol 84:225-236.
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214.
Castillo M, Scheen A, Lefèbvre PJ, Luyckx AS (1985) Insulin‐stimulated glucose disposal is not increased in anorexia nervosa. J Clin Endocrinol Metab 60:311-314.
Verdonk CA, Rizza RA, Westland RE, Nelson RL, Gerich JE, Service FJ (1980) Glucose clamping using the Biostator GCIIS. Horm Metab Res 12:133-135.
Olefsky JM (1976) Decreased insulin binding to adipocytes and circulating monocytes from obese subjects. J Clin Invest 57:1165-1172.
Wachslicht‐Rodbard H, Gross HA, Rodbard D, Ebert MH, Roth J (1979) Increased insulin binding to erythrocytes in anorexia nervosa. Restoration to normal with refeeding. New England Journal of Medicine 300:882-887.
Kumai M, Tamai H, Fujii S, Nakagawa T, Aoki TT (1988) Glucagon secretion in anorexia nervosa. Am J Clin Nutr 47:239-242.